Meditation-Relaxation (MR Therapy) for Sleep Paralysis.
Not Applicable
- Conditions
- Narcolepsy Type 1Sleep Paralysis
- Interventions
- Behavioral: MR therapy.Behavioral: breathing-distraction exercise
- Registration Number
- NCT04483310
- Lead Sponsor
- Azienda Usl di Bologna
- Brief Summary
The aim of the study is to evaluate, with a small-scale pilot study, the efficacy of Meditation Relaxation therapy for Sleep Paralyses in patients with narcolepsy. The study involves two arms, with intervention with Meditation Relaxation therapy or sham over a period of three months.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
- Narcolepsy (type 1 and 2) based on polysomnography, Multiple Sleep Latency Test [MLST] and CSF hypocretin level testing).
- Patients had to have experienced SP at least four times in the last month.
Read More
Exclusion Criteria
- Psychiatric comorbidity.
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description MR therapy MR therapy. MR therapy is a psychological treatment for SP, comprised of the following steps applied directly during the attack: Step I: Reappraisal of the meaning of the attack; Step II: psychological and emotional distancing; Step III: inward focused-attention meditation; Step IV: Muscle relaxation. Control intervention breathing-distraction exercise The control intervention was identical, except participants engaged in deep breathing; entailing slow deep breaths, while repeatedly counting from 1-10. This is an active control (breathing-distraction exercise) rather than a placebo.
- Primary Outcome Measures
Name Time Method Sleep Paralysis Experiences and Phenomenology Questionnaire (SP-EPQ) Three months. The questionnaire addresses the distress associated with SP.
- Secondary Outcome Measures
Name Time Method Daily journal Three months. Each day during the study (12 weeks), participants rated their SP occurrence, perceived duration (sec./min.), fear associated with SP, and disturbance caused by hallucinations (on a ten-point scale).
Trial Locations
- Locations (1)
Azienda USL di Bologna
🇮🇹Bologna, Italy